C07K 16/205
Plasmodium
Official title: {Plasmodium}
C07K16/205 (Plasmodium) appears on 149 US grants and 172 published applications in this corpus.
Search patents in C07K- Granted patents
- 149
- Published applications
- 172
- Assignees
- 123
- Inventors
- 428
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 8 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 1 | 5 |
| 2003 | 1 | 3 |
| 2004 | 2 | 3 |
| 2005 | 1 | 5 |
| 2006 | 4 | 8 |
| 2007 | 1 | 5 |
| 2008 | 3 | 4 |
| 2009 | 4 | 5 |
| 2010 | 4 | 9 |
| 2011 | 3 | 5 |
| 2012 | 7 | 8 |
| 2013 | 5 | 4 |
| 2014 | 5 | 8 |
| 2015 | 3 | 6 |
| 2016 | 2 | 7 |
| 2017 | 8 | 8 |
| 2018 | 6 | 11 |
| 2019 | 9 | 8 |
| 2020 | 3 | 7 |
| 2021 | 7 | 12 |
| 2022 | 4 | 7 |
| 2023 | 8 | 13 |
| 2024 | 4 | 8 |
| 2025 | 8 | 7 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof10 Feb 2026US 12,544,441 B2University of South Florida
- Anti-CSP antibodies10 Feb 2026US 12,545,723 B2Atreca, Inc.
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof26 Aug 2025US 12,398,184 B2University of South Florida
- Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to12 Aug 2025US 12,383,609 B2Institute for Research in Biomedicine
- Treatment and prevention of malaria5 Aug 2025US 12,377,138 B2Oxford University Innovation Limited
- Novel methods of generating antibodies24 Sep 2026US 2026/0285952 A1Rutgers, The State University of New Jersey
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Vaccine6 Aug 2026US 2026/0224681 A1Oxford University Innovation Limited
- Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to6 Aug 2026US 2026/0224682 A1Institute for Research in Biomedicine
- Anti-csp antibody variants6 Aug 2026US 2026/0226147 A1Atreca, Inc.
Most cited
By later US patents
- Retro-, inverso- and retro-inverso synthetic peptide analogues90US 6,261,569 B1Deakin Research Limited · 2001
- Malaria vaccine82US 4,466,917 ANew York University · 1984
- Monoclonal antibodies to a pan-malarial antigen81US 5,001,225 AGeorgetown University · 1991
- Malaria antigen42US 5,231,168 AStatens Seruminstitut · 1993
- Recombinant vector containing a sequence of a lipoprotein gene for the expression of nucleotide sequences34US 6,130,085 A2000